Clinical trial of new dyskinesia drug starts in Sweden
Date
Research news
Promising results from a phase II study for people with early-stage Parkinson’s
Date
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Prostate drug shows promise in Parkinson’s
Date
A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Scientists uncover further evidence that Parkinson's could start in the gut
Date
New research in rats has shown that alpha-synuclein, an abnormal protein normally found in brain cells affected in Parkinson's, can move rapidly from the gut to the brain. These findings support growing evidence that Parkinson’s may start in the gut rather than the brain.